Get latest articles and stories on Latest News at LatestLY. Shares of Glenmark Pharmaceuticals on Friday fell over 6 per cent after the company said its board has approved divestment of 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore. Latest News | Glenmark Pharma Shares Fall over 6 Pc After Nirma Deal.
Glenmark board approves to sell 75 pc in Glenmark Life Sciences to Nirma for Rs 5,651 5 crore financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
BW Businessworld
Glenmark Q3 Net Profit Up 30% At Rs 248.17 Cr
Sales from the formulation business in India for the third quarter of FY 2020-21 was at Rs 882.11 crore as against Rs 788.83 crore in the previous corresponding quarter
Photo Credit : Shutterstock
Drug firm Glenmark Pharmaceuticals on Friday reported a 30.04 percent rise in its consolidated net profit to Rs 248.17 crore for the quarter ended December 2020, mainly on account of robust sales in India and growth in the API segment.
The company had posted a net profit of Rs 190.83 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a regulatory filing.